Paper Details

  1. Home
  2. Paper Details

[Non-hormonal treatment for vasomotor symptoms during menopause: role of desvenlafaxine].

Author: LilueMariella, PalaciosSantiago

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor, has shown efficacy for vasomotor symptoms (VMS). However, it also increased the incidence of minor side effects, especially nausea, at the beginning of treatment.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To review the published data that include Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), especially desvenlafaxine, on vasomotor symptoms (VMS). METHODS: This review is based on published data in Medline (1990-2009) for studies o...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/19902676

データ提供：米国国立医学図書館（NLM）

Desvenlafaxine: A New Hope for Menopausal Vasomotor Symptoms

Menopause, a natural transition in a woman's life, can sometimes be accompanied by uncomfortable vasomotor symptoms (VMS), such as hot flashes and night sweats. This research explores the potential of desvenlafaxine, a non-hormonal medication, in alleviating these bothersome symptoms.

Beyond Hormones: A Non-Hormonal Approach

The researchers reviewed studies on desvenlafaxine and found evidence for its efficacy in reducing VMS. They emphasize the need for non-hormonal alternatives for women who cannot or choose not to take hormone therapy. The research suggests that desvenlafaxine, by influencing the neurotransmitters involved in temperature regulation, offers a viable option for managing VMS.

Navigating Menopause with Confidence

This research provides valuable information for women experiencing VMS. It underscores the importance of exploring all available treatment options with their doctor to find the best approach for their individual needs. While desvenlafaxine may offer relief, it is crucial to be aware of potential side effects and discuss them with your healthcare provider.

Dr. Camel's Conclusion

Desvenlafaxine offers a new path for women navigating the often-unpredictable terrain of menopause. Its non-hormonal approach provides a welcome alternative for women seeking relief from VMS. Remember, like navigating a desert, it's important to seek guidance from a healthcare professional to find the best path for your individual journey.
Date :
  1. Date Completed 2010-01-06
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

19902676

DOI: Digital Object Identifier

19902676

Related Literature

Article Analysis
・Side Effects of desvenlafaxine
SNS
PICO Info
in preparation
Languages

Spanish

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.